BBRRF (Blueberries Medical) Net Debt Paydown Yield % : -1.72% (As of Jul. 12, 2026)


What is Blueberries Medical Net Debt Paydown Yield %?

Blueberries Medical BBRRF Net Debt Paydown Yield % is -1.72% as of Jul. 12, 2026. The stock has 2 warning signs investors should review. Among 923 Drug Manufacturers companies, Blueberries Medical ranks worse than 67.06% on this metric.

Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt. As of today, Blueberries Medical's Net Debt Paydown Yield % was -1.72%.


Blueberries Medical  (OTCPK:BBRRF) Net Debt Paydown Yield % Explanation

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.

In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.

We calculating the TTM average debt by adding up the total debt, calculated by the sum of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation, in the trailing twelve months(TTM) divided by the counts of the total debt, accoring to the company's report frequency.


Blueberries Medical Net Debt Paydown Yield % Related Terms


Blueberries Medical Net Debt Paydown Yield % Historical Data

* Premium members only.

The historical data trend for Blueberries Medical's Net Debt Paydown Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Blueberries Medical Net Debt Paydown Yield % Chart

Blueberries Medical Annual Data
Trend Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Debt Paydown Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.12 0.45 3.52 28.73 -0.63

Blueberries Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Debt Paydown Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.93 5.37 0.02 -0.63 -1.14

BBRRF vs ZTS, UTHR: Net Debt Paydown Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blueberries Medical Net Debt Paydown Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's Net Debt Paydown Yield % distribution charts can be found below:

* The bar in red indicates where Blueberries Medical's Net Debt Paydown Yield % falls into.



Blueberries Medical Net Debt Paydown Yield % Calculation

Blueberries Medical's Net Debt Paydown Yield % for the quarter that ended in Mar. 2026 is calculated as:

Net Debt Paydown Yield %
=( TTM Average Debt   (1-Year Ago))-TTM Average Debt )/Market Cap
=( 0.01-0.07 )/5.94108
=-1.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

What does a Net Debt Paydown Yield % of -1.72% mean?
Blueberries Medical (BBRRF) has a Net Debt Paydown Yield % of -1.72% as of Jul. 12, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Blueberries Medical and its competitors. According to the industry distribution chart, Blueberries Medical ranks #619 out of 923 companies in the Drug Manufacturers industry, placing it in the top 67.1%.
Is Blueberries Medical's Net Debt Paydown Yield % too high?
Blueberries Medical's current Net Debt Paydown Yield % is -1.72%. Based on the distribution chart, Blueberries Medical ranks #619 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Blueberries Medical's Net Debt Paydown Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Blueberries Medical ranks #619 out of 923 companies for Net Debt Paydown Yield %. This places Blueberries Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Drug Manufacturers company?
A good Net Debt Paydown Yield % depends on the Drug Manufacturers industry context. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Blueberries Medical and its competitors. Blueberries Medical's current Net Debt Paydown Yield % is -1.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blueberries Medical stock overvalued right now?
Blueberries Medical (BBRRF) has a current Net Debt Paydown Yield % of -1.72%. The current Net Debt Paydown Yield % is -1.72%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For Blueberries Medical (BBRRF), the current Net Debt Paydown Yield % is -1.72% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Blueberries Medical Business Description

Other Exchanges 1OA:GermanyBBM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Blueberries Medical Corp is a consumer science company focused on health, wellness and longevity. The company also distributes functional supplements, wellness products, and natural ingredients. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.